.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Dow
Citi
McKinsey
QuintilesIMS
Novartis
Argus Health
Chubb
Fish and Richardson
Covington

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086283

« Back to Dashboard
NDA 086283 describes LIDOCAINE HYDROCHLORIDE, which is a drug marketed by Intl Medication, West-ward Pharms Int, Belmora Llc, Abraxis Pharm, Bel Mar, Vintage, Hospira, Miles, Hi Tech Pharma, G And W Labs Inc, Elkins Sinn, Watson Labs, Akorn, Gd Searle Llc, Watson Labs Inc, Mylan Labs Ltd, Luitpold, Abbott, Luitpold Pharms Inc, Wockhardt, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Teligent Pharma Inc, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Fresenius Kabi Usa, Aurobindo Pharma Ltd, and Actavis Mid Atlantic, and is included in ninety-three NDAs. It is available from thirty-one suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE profile page.

The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for NDA: 086283

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 086283

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 086283

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
 JELLY;TOPICAL 086283 ANDA General Injectables & Vaccines, Inc 52584-030 52584-030-05 1 VIAL, SINGLE-USE in 1 BAG (52584-030-05) > 5 mL in 1 VIAL, SINGLE-USE
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
 JELLY;TOPICAL 086283 ANDA General Injectables & Vaccines, Inc 52584-034 52584-034-05 1 VIAL, SINGLE-USE in 1 BAG (52584-034-05) > 10 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:JELLY;TOPICALStrength2%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Express Scripts
US Department of Justice
AstraZeneca
Cipla
UBS
McKinsey
US Army
Citi
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot